MetaCap

Propanc Biopharma Inc. Company Profile

NASDAQ: PPCBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.78+0.055 (+3.19%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Propanc Biopharma at a glance

Propanc Biopharma Inc. (NASDAQ: PPCB) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Camberwell, VIC, Australia. Propanc Biopharma is led by Mr. James Nathanielsz and employs about 2 people. At a market capitalization of $1.8 million, it is considered a small-cap company.

Its SEC Central Index Key (CIK) is 0001517681, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Propanc Biopharma do?

Propanc Biopharma, Inc., a development-stage biopharmaceutical healthcare company, engages in the development of cancer treatments for patients with pancreatic, ovarian, and colorectal cancers in Australia. Its lead product candidate is PRP, an intravenous injection proenzyme treatment designed as a therapeutic option in cancer treatment and prevention which has completed pre-clinical studies. The company has a research and collaboration agreement with the University of Jaén, to undertakes the research activities for the POP1 Program and the University of Granada to develop a synthetic recombinant version of PRP. Propanc Biopharma, Inc. was formerly known as Propanc Health Group Corporation and changed its name to Propanc Biopharma, Inc. in April 2017. The company was incorporated in 2007 and is based in Camberwell, Australia.

Business description based on the company's public filings.

Company information

Legal name
Propanc Biopharma Inc.
Ticker
NASDAQ: PPCB
Industry
Biotechnology: Pharmaceutical Preparations
CEO
Mr. James Nathanielsz
Employees
2
Headquarters
302, 6 Butler Street, Camberwell, VIC, Australia
Phone
61 3 9882 0780
SEC CIK
0001517681
Latest annual report
10-K · Sep 25, 2026

Companies similar to Propanc Biopharma

PPCB peer companies
CompanyPrice% ChgMarket capCompare
SBFMSunshine Biopharma Inc.2.23-5.11%$1.84Mvs PPCB
PPBTPurple Biotech Ltd. ADR1.53-4.09%$1.86Mvs PPCB
XRTXXORTX Therapeutics Inc.0.839-5.73%$1.88Mvs PPCB
EOCNEocene Ltd.1.78+1.73%$1.90Mvs PPCB
KALAKALA BIO Inc.2.71-10.28%$1.74Mvs PPCB
GNPXGenprex Inc.1.45-13.17%$1.94Mvs PPCB
DCOYDecoy Therapeutics Inc.0.8294-4.68%$1.98Mvs PPCB
REVBRevelation Biosciences Inc.3.50-5.15%$1.99Mvs PPCB

Related